[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Impact of Pulmonary fibrosis on In-Hospital Outcomes in Patients Hospitalized with RA: A National Inpatient Sample Study",
    "section": "",
    "text": "Study Objective: To examine the impact of pulmonary fibrosis on in-hospital outcomes in adults with rheumatoid arthritis.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020. The NIS is part of the Healthcare Cost and Utilization Project (HCUP) and provides a stratified sample of inpatient discharges from U.S. community hospitals across all payers.\nCohort Definition: Patients were included if they met the following criteria\n\nAge ≥ 18 years\nHad a diagnosis of rheumatoid arthritis (ICD 10: M05., M06)\nInformation for pulmonary fibrosis (ICD 10: J84.1) was not missing\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2021 ($)\n\nSecondary Outcomes:\n\nRespiratory failure\nRequiring mechanical ventilation\nSepsis\nPneumonia\nPneumothorax\nPulmonary embolism\nNon-home discharge\n\nCovariates for Adjustment: All models adjusted for the following\n\nDemographics: Age, sex, race, income, insurance, location of patient’s residence, hospital region, hospital bedsize, hospital location, and teaching status.\nMedical History: Hypertension, diabetes mellitus, coronary artery disease, chronic kidney disease, heart failure, chronic kidney disease.\n\nStatistical Methods:\n\nUnivariable Analysis:\n\nCategorical variables: Compared using Pearson’s chi-square test with Rao & Scott adjustment\nContinuous variables: Analyzed using the design-based Kruskal–Wallis test, a non-parametric alternative suitable for survey-weighted data\n\nMultivariable Analysis:\n\nBinary outcomes (e.g., mortality): Survey-weighted logistic regression using the quasibinomial family\nContinuous outcomes (e.g., LOS, hospital charges): Survey-weighted linear regression using the gaussian family\nResults reported as adjusted odds ratios (aORs) or beta coefficients with 95% confidence intervals\n\n\nSoftware: All statistical analyses were performed using the R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria), incorporating survey-weighted procedures via the survey package to account for the complex sampling design of NIS."
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Impact of Pulmonary fibrosis on In-Hospital Outcomes in Patients Hospitalized with RA: A National Inpatient Sample Study",
    "section": "",
    "text": "Study Objective: To examine the impact of pulmonary fibrosis on in-hospital outcomes in adults with rheumatoid arthritis.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020. The NIS is part of the Healthcare Cost and Utilization Project (HCUP) and provides a stratified sample of inpatient discharges from U.S. community hospitals across all payers.\nCohort Definition: Patients were included if they met the following criteria\n\nAge ≥ 18 years\nHad a diagnosis of rheumatoid arthritis (ICD 10: M05., M06)\nInformation for pulmonary fibrosis (ICD 10: J84.1) was not missing\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2021 ($)\n\nSecondary Outcomes:\n\nRespiratory failure\nRequiring mechanical ventilation\nSepsis\nPneumonia\nPneumothorax\nPulmonary embolism\nNon-home discharge\n\nCovariates for Adjustment: All models adjusted for the following\n\nDemographics: Age, sex, race, income, insurance, location of patient’s residence, hospital region, hospital bedsize, hospital location, and teaching status.\nMedical History: Hypertension, diabetes mellitus, coronary artery disease, chronic kidney disease, heart failure, chronic kidney disease.\n\nStatistical Methods:\n\nUnivariable Analysis:\n\nCategorical variables: Compared using Pearson’s chi-square test with Rao & Scott adjustment\nContinuous variables: Analyzed using the design-based Kruskal–Wallis test, a non-parametric alternative suitable for survey-weighted data\n\nMultivariable Analysis:\n\nBinary outcomes (e.g., mortality): Survey-weighted logistic regression using the quasibinomial family\nContinuous outcomes (e.g., LOS, hospital charges): Survey-weighted linear regression using the gaussian family\nResults reported as adjusted odds ratios (aORs) or beta coefficients with 95% confidence intervals\n\n\nSoftware: All statistical analyses were performed using the R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria), incorporating survey-weighted procedures via the survey package to account for the complex sampling design of NIS."
  },
  {
    "objectID": "quarto/index.html#descriptive-analysis",
    "href": "quarto/index.html#descriptive-analysis",
    "title": "Impact of Pulmonary fibrosis on In-Hospital Outcomes in Patients Hospitalized with RA: A National Inpatient Sample Study",
    "section": "Descriptive analysis",
    "text": "Descriptive analysis\n\nBaseline Characteristics:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 27,9151\nWithout pulmonary fibrosis\nN = 26,8051\nWith pulmonary fibrosis\nN = 1,1101\np-value2\n\n\n\n\nAge, y\n65 (53, 74)\n65 (53, 74)\n71 (64, 78)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n0.3\n\n\n    Female\n19,520 (70%)\n18,780 (70%)\n740 (67%)\n\n\n\n\n    Male\n8,390 (30%)\n8,020 (30%)\n370 (33%)\n\n\n\n\nRace\n\n\n\n\n\n\n0.001\n\n\n    White\n16,710 (62%)\n15,930 (61%)\n780 (72%)\n\n\n\n\n    Black\n4,810 (18%)\n4,675 (18%)\n135 (13%)\n\n\n\n\n    Hispanic\n3,750 (14%)\n3,605 (14%)\n145 (13%)\n\n\n\n\n    Other\n1,895 (7.0%)\n1,875 (7.2%)\n20 (1.9%)\n\n\n\n\nResidential income\n\n\n\n\n\n\n0.8\n\n\n    $1 - $51,999\n8,325 (30%)\n8,015 (30%)\n310 (29%)\n\n\n\n\n    $52,000 - $65,999\n6,795 (25%)\n6,495 (25%)\n300 (28%)\n\n\n\n\n    $66,000 - $87,999\n6,710 (24%)\n6,455 (24%)\n255 (24%)\n\n\n\n\n    $88,000 or more\n5,720 (21%)\n5,500 (21%)\n220 (20%)\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n&lt;0.001\n\n\n    Private\n7,520 (27%)\n7,335 (27%)\n185 (17%)\n\n\n\n\n    Medicaid\n3,810 (14%)\n3,750 (14%)\n60 (5.4%)\n\n\n\n\n    Medicare\n16,010 (57%)\n15,160 (57%)\n850 (77%)\n\n\n\n\n    Other\n510 (1.8%)\n495 (1.9%)\n15 (1.4%)\n\n\n\n\nHospital region\n\n\n\n\n\n\n0.2\n\n\n    Midwest\n6,480 (23%)\n6,170 (23%)\n310 (28%)\n\n\n\n\n    Northeast\n5,970 (21%)\n5,735 (21%)\n235 (21%)\n\n\n\n\n    South\n9,660 (35%)\n9,265 (35%)\n395 (36%)\n\n\n\n\n    West\n5,805 (21%)\n5,635 (21%)\n170 (15%)\n\n\n\n\nHospital bedsize\n\n\n\n\n\n\n0.028\n\n\n    Large\n13,960 (50%)\n13,320 (50%)\n640 (58%)\n\n\n\n\n    Medium\n7,450 (27%)\n7,235 (27%)\n215 (19%)\n\n\n\n\n    Small\n6,505 (23%)\n6,250 (23%)\n255 (23%)\n\n\n\n\nHospital location and teaching status\n\n\n\n\n\n\n0.6\n\n\n    Rural\n2,130 (7.6%)\n2,035 (7.6%)\n95 (8.6%)\n\n\n\n\n    Urban, non-teaching\n4,955 (18%)\n4,785 (18%)\n170 (15%)\n\n\n\n\n    Urban, teaching\n20,830 (75%)\n19,985 (75%)\n845 (76%)\n\n\n\n\nDiabetes mellitus\n4,665 (17%)\n4,480 (17%)\n185 (17%)\n&gt;0.9\n\n\nHypertension\n2,665 (9.5%)\n2,610 (9.7%)\n55 (5.0%)\n0.016\n\n\nChronic kidney disease\n3,720 (13%)\n3,585 (13%)\n135 (12%)\n0.6\n\n\nHeart failure\n3,575 (13%)\n3,250 (12%)\n325 (29%)\n&lt;0.001\n\n\nCoronary artery disease\n3,980 (14%)\n3,655 (14%)\n325 (29%)\n&lt;0.001\n\n\n\n1 Median (Q1, Q3); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment\n\n\n\n\n\n\n\n\n\n\nOutcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 27,9151\nWithout pulmonary fibrosis\nN = 26,8051\nWith pulmonary fibrosis\nN = 1,1101\np-value2\n\n\n\n\nDied during hospitalization\n275 (1.0%)\n170 (0.6%)\n105 (9.5%)\n&lt;0.001\n\n\nLength of stay (days)\n3.0 (2.0, 5.0)\n3.0 (2.0, 5.0)\n4.0 (2.0, 9.0)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n41,112 (23,160, 71,069)\n41,110 (23,079, 70,925)\n42,657 (25,032, 75,658)\n0.3\n\n\nMechanical ventilation\n205 (0.7%)\n155 (0.6%)\n50 (4.5%)\n&lt;0.001\n\n\nRespiratory failure\n2,360 (8.5%)\n1,675 (6.2%)\n685 (62%)\n&lt;0.001\n\n\nPneumonia\n1,105 (4.0%)\n930 (3.5%)\n175 (16%)\n&lt;0.001\n\n\nPneumothorax\n60 (0.2%)\n45 (0.2%)\n15 (1.4%)\n&lt;0.001\n\n\nPulmonary embolism\n145 (0.5%)\n115 (0.4%)\n30 (2.7%)\n&lt;0.001\n\n\nNon-home discharge\n5,800 (21%)\n5,465 (20%)\n335 (30%)\n&lt;0.001\n\n\n\n1 n (%); Median (Q1, Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Impact of Pulmonary fibrosis on In-Hospital Outcomes in Patients Hospitalized with RA: A National Inpatient Sample Study",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nIn-hospital mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPulmonary fibrosis categories\n\n\n\n\n\n\n\n\n    Without pulmonary fibrosis\n—\n—\n\n\n\n\n    With pulmonary fibrosis\n12.0\n6.23, 23.1\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.35\n0.77, 2.36\n0.3\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n0.40\n0.13, 1.19\n0.10\n\n\n    Hispanic\n0.46\n0.15, 1.44\n0.2\n\n\n    Other\n0.65\n0.15, 2.88\n0.6\n\n\nAge, y\n1.01\n0.98, 1.04\n0.6\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.59\n0.26, 1.33\n0.2\n\n\n    $66,000 - $87,999\n0.60\n0.25, 1.44\n0.3\n\n\n    $88,000 or more\n0.60\n0.25, 1.43\n0.2\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.34\n0.07, 1.53\n0.2\n\n\n    Medicare\n0.79\n0.33, 1.88\n0.6\n\n\n    Other\n1.32\n0.16, 10.9\n0.8\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.92\n0.38, 2.23\n0.9\n\n\n    South\n0.76\n0.35, 1.67\n0.5\n\n\n    West\n1.43\n0.60, 3.45\n0.4\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.60\n0.28, 1.29\n0.2\n\n\n    Small\n0.54\n0.24, 1.20\n0.13\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.29\n0.44, 3.75\n0.6\n\n\n    Urban, teaching\n0.76\n0.28, 2.05\n0.6\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.43\n0.05, 3.81\n0.4\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.76\n0.33, 1.77\n0.5\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.96\n0.48, 1.94\n&gt;0.9\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.49\n0.15, 1.56\n0.2\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3.57\n1.75, 7.29\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nMechanical Ventilation:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPulmonary fibrosis categories\n\n\n\n\n\n\n\n\n    Without pulmonary fibrosis\n—\n—\n\n\n\n\n    With pulmonary fibrosis\n6.87\n3.01, 15.7\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.52\n0.81, 2.85\n0.2\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n0.50\n0.16, 1.57\n0.2\n\n\n    Hispanic\n0.69\n0.24, 2.02\n0.5\n\n\n    Other\n1.05\n0.34, 3.25\n&gt;0.9\n\n\nAge, y\n1.01\n0.98, 1.04\n0.6\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.56\n0.23, 1.37\n0.2\n\n\n    $66,000 - $87,999\n0.81\n0.36, 1.82\n0.6\n\n\n    $88,000 or more\n0.50\n0.18, 1.38\n0.2\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.79\n0.26, 2.37\n0.7\n\n\n    Medicare\n0.47\n0.19, 1.15\n0.10\n\n\n    Other\n2.15\n0.42, 11.0\n0.4\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.60\n0.20, 1.80\n0.4\n\n\n    South\n1.17\n0.53, 2.60\n0.7\n\n\n    West\n0.82\n0.29, 2.32\n0.7\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.74\n0.35, 1.60\n0.4\n\n\n    Small\n0.36\n0.12, 1.07\n0.065\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n3.47\n0.48, 25.3\n0.2\n\n\n    Urban, teaching\n4.89\n0.72, 33.4\n0.11\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.67\n0.56, 5.03\n0.4\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.71\n0.86, 3.41\n0.13\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.86\n0.39, 1.91\n0.7\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.33, 2.17\n0.7\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3.62\n1.67, 7.85\n0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nRespiratory Failure:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPulmonary fibrosis categories\n\n\n\n\n\n\n\n\n    Without pulmonary fibrosis\n—\n—\n\n\n\n\n    With pulmonary fibrosis\n21.1\n14.8, 29.9\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.03\n0.82, 1.31\n0.8\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n0.73\n0.53, 1.02\n0.064\n\n\n    Hispanic\n0.85\n0.59, 1.21\n0.4\n\n\n    Other\n0.93\n0.58, 1.49\n0.8\n\n\nAge, y\n1.01\n1.00, 1.02\n0.011\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.20\n0.88, 1.63\n0.2\n\n\n    $66,000 - $87,999\n1.16\n0.84, 1.61\n0.4\n\n\n    $88,000 or more\n0.96\n0.69, 1.33\n0.8\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.02\n0.67, 1.55\n&gt;0.9\n\n\n    Medicare\n0.98\n0.72, 1.33\n0.9\n\n\n    Other\n1.37\n0.61, 3.04\n0.4\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.80\n0.56, 1.13\n0.2\n\n\n    South\n1.07\n0.79, 1.46\n0.7\n\n\n    West\n0.99\n0.69, 1.41\n&gt;0.9\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.90\n0.69, 1.17\n0.4\n\n\n    Small\n0.82\n0.61, 1.08\n0.2\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.80\n0.49, 1.31\n0.4\n\n\n    Urban, teaching\n1.06\n0.69, 1.63\n0.8\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.26\n0.78, 2.03\n0.4\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.17\n0.89, 1.55\n0.3\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.19\n0.89, 1.59\n0.2\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.74\n0.51, 1.07\n0.11\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n4.73\n3.54, 6.34\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nPneumonia:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPulmonary fibrosis categories\n\n\n\n\n\n\n\n\n    Without pulmonary fibrosis\n—\n—\n\n\n\n\n    With pulmonary fibrosis\n4.44\n2.90, 6.80\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.32\n0.98, 1.79\n0.071\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n0.88\n0.57, 1.34\n0.5\n\n\n    Hispanic\n1.21\n0.79, 1.84\n0.4\n\n\n    Other\n1.08\n0.60, 1.94\n0.8\n\n\nAge, y\n1.01\n1.00, 1.02\n0.15\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.72\n1.18, 2.50\n0.004\n\n\n    $66,000 - $87,999\n1.38\n0.92, 2.08\n0.12\n\n\n    $88,000 or more\n1.09\n0.68, 1.73\n0.7\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.32\n0.79, 2.22\n0.3\n\n\n    Medicare\n1.22\n0.80, 1.86\n0.3\n\n\n    Other\n2.97\n1.37, 6.43\n0.006\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.19\n0.75, 1.87\n0.5\n\n\n    South\n1.49\n1.01, 2.22\n0.046\n\n\n    West\n1.07\n0.66, 1.75\n0.8\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.88\n0.63, 1.24\n0.5\n\n\n    Small\n0.81\n0.56, 1.18\n0.3\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.74\n0.39, 1.38\n0.3\n\n\n    Urban, teaching\n1.03\n0.59, 1.78\n&gt;0.9\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.34\n0.74, 2.42\n0.3\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.06\n0.73, 1.53\n0.8\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.94\n0.64, 1.37\n0.7\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.98\n0.60, 1.61\n&gt;0.9\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.45\n1.65, 3.64\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nPneumothorax:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPulmonary fibrosis categories\n\n\n\n\n\n\n\n\n    Without pulmonary fibrosis\n—\n—\n\n\n\n\n    With pulmonary fibrosis\n4.02\n1.03, 15.7\n0.045\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n2.28\n0.68, 7.63\n0.2\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n0.00\n0.00, 0.00\n&lt;0.001\n\n\n    Hispanic\n0.00\n0.00, 0.00\n&lt;0.001\n\n\n    Other\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nAge, y\n1.05\n1.02, 1.08\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.37\n0.06, 2.12\n0.3\n\n\n    $66,000 - $87,999\n0.54\n0.10, 2.97\n0.5\n\n\n    $88,000 or more\n0.47\n0.08, 2.57\n0.4\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.00\n0.00, 0.00\n&lt;0.001\n\n\n    Medicare\n0.39\n0.11, 1.41\n0.15\n\n\n    Other\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.06\n0.25, 4.49\n&gt;0.9\n\n\n    South\n0.35\n0.06, 2.12\n0.3\n\n\n    West\n0.66\n0.13, 3.53\n0.6\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.00\n0.00, 0.00\n&lt;0.001\n\n\n    Small\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n102,504,312\n14,075,031, 746,508,745\n&lt;0.001\n\n\n    Urban, teaching\n218,738,911\n74,795,975, 639,696,341\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.34\n0.28, 6.32\n0.7\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.81\n0.55, 5.91\n0.3\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.00\n0.00, 0.00\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.58\n0.06, 5.16\n0.6\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nPulmonary Embolism:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPulmonary fibrosis categories\n\n\n\n\n\n\n\n\n    Without pulmonary fibrosis\n—\n—\n\n\n\n\n    With pulmonary fibrosis\n6.30\n2.25, 17.6\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.11\n0.49, 2.52\n0.8\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.37\n0.47, 4.01\n0.6\n\n\n    Hispanic\n0.75\n0.20, 2.87\n0.7\n\n\n    Other\n1.06\n0.25, 4.45\n&gt;0.9\n\n\nAge, y\n0.97\n0.94, 1.00\n0.028\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n3.44\n1.05, 11.3\n0.041\n\n\n    $66,000 - $87,999\n3.02\n0.85, 10.8\n0.088\n\n\n    $88,000 or more\n1.77\n0.44, 7.03\n0.4\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.20\n0.02, 1.80\n0.2\n\n\n    Medicare\n1.49\n0.59, 3.72\n0.4\n\n\n    Other\n1.85\n0.21, 15.9\n0.6\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.88\n0.53, 6.65\n0.3\n\n\n    South\n1.51\n0.48, 4.75\n0.5\n\n\n    West\n2.89\n0.84, 9.96\n0.092\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.67\n0.25, 1.79\n0.4\n\n\n    Small\n0.67\n0.25, 1.83\n0.4\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.37\n0.07, 1.88\n0.2\n\n\n    Urban, teaching\n0.66\n0.19, 2.24\n0.5\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.36\n0.04, 3.53\n0.4\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.62\n0.18, 2.09\n0.4\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.74\n0.20, 2.71\n0.7\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.35\n0.33, 5.56\n0.7\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.32\n0.76, 7.07\n0.14\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nNon-Home Discharge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPulmonary fibrosis categories\n\n\n\n\n\n\n\n\n    Without pulmonary fibrosis\n—\n—\n\n\n\n\n    With pulmonary fibrosis\n1.25\n0.90, 1.73\n0.2\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.00\n0.86, 1.16\n&gt;0.9\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n1.32\n1.09, 1.60\n0.005\n\n\n    Hispanic\n0.93\n0.74, 1.19\n0.6\n\n\n    Other\n0.70\n0.51, 0.97\n0.033\n\n\nAge, y\n1.03\n1.02, 1.03\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.04\n0.86, 1.25\n0.7\n\n\n    $66,000 - $87,999\n1.05\n0.86, 1.28\n0.6\n\n\n    $88,000 or more\n0.95\n0.76, 1.17\n0.6\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.70\n1.27, 2.29\n&lt;0.001\n\n\n    Medicare\n2.32\n1.85, 2.92\n&lt;0.001\n\n\n    Other\n1.74\n0.96, 3.16\n0.069\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.33\n1.08, 1.64\n0.008\n\n\n    South\n1.07\n0.88, 1.29\n0.5\n\n\n    West\n1.05\n0.84, 1.31\n0.7\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.99\n0.84, 1.17\n0.9\n\n\n    Small\n1.05\n0.88, 1.25\n0.6\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.96\n0.70, 1.31\n0.8\n\n\n    Urban, teaching\n0.93\n0.70, 1.24\n0.6\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.35\n0.99, 1.83\n0.055\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.01\n0.85, 1.21\n&gt;0.9\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.76, 1.12\n0.4\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.95\n0.72, 1.24\n0.7\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.45\n1.16, 1.81\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Impact of Pulmonary fibrosis on In-Hospital Outcomes in Patients Hospitalized with RA: A National Inpatient Sample Study",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nPulmonary fibrosis categories\n\n\n\n\n\n\n\n\n    Without pulmonary fibrosis\n—\n—\n\n\n\n\n    With pulmonary fibrosis\n2.7\n1.3, 4.0\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.45\n0.08, 0.81\n0.017\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n0.27\n-0.21, 0.74\n0.3\n\n\n    Hispanic\n-0.13\n-0.77, 0.50\n0.7\n\n\n    Other\n0.33\n-0.40, 1.1\n0.4\n\n\nAge, y\n0.01\n0.00, 0.03\n0.15\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.15\n-0.57, 0.87\n0.7\n\n\n    $66,000 - $87,999\n-0.46\n-1.2, 0.28\n0.2\n\n\n    $88,000 or more\n-0.23\n-1.0, 0.55\n0.6\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.90\n0.20, 1.6\n0.012\n\n\n    Medicare\n-0.15\n-0.65, 0.34\n0.5\n\n\n    Other\n1.1\n0.08, 2.1\n0.034\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.56\n0.11, 1.0\n0.015\n\n\n    South\n0.41\n-0.05, 0.87\n0.084\n\n\n    West\n0.34\n-0.41, 1.1\n0.4\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-0.89\n-1.5, -0.30\n0.003\n\n\n    Small\n-1.2\n-1.6, -0.85\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.70\n-0.38, 1.8\n0.2\n\n\n    Urban, teaching\n0.82\n0.19, 1.4\n0.010\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.96\n-0.25, 2.2\n0.12\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.39\n-0.08, 0.86\n0.10\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.28\n-0.72, 0.16\n0.2\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.29\n-1.2, 0.66\n0.6\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.8\n1.1, 2.6\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nTotal hospital charges:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nPulmonary fibrosis categories\n\n\n\n\n\n\n\n\n    Without pulmonary fibrosis\n—\n—\n\n\n\n\n    With pulmonary fibrosis\n30,161\n3,968, 56,354\n0.024\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n-1,030\n-8,902, 6,842\n0.8\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Black\n-4,772\n-10,948, 1,403\n0.13\n\n\n    Hispanic\n1,565\n-6,223, 9,353\n0.7\n\n\n    Other\n-169\n-8,214, 7,876\n&gt;0.9\n\n\nAge, y\n8.5\n-228, 245\n&gt;0.9\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n7,353\n440, 14,265\n0.037\n\n\n    $66,000 - $87,999\n6,138\n-1,554, 13,829\n0.12\n\n\n    $88,000 or more\n6,679\n-832, 14,191\n0.081\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-10,244\n-20,276, -212\n0.045\n\n\n    Medicare\n-9,916\n-21,497, 1,664\n0.093\n\n\n    Other\n-2,617\n-16,976, 11,741\n0.7\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n17,898\n7,160, 28,635\n0.001\n\n\n    South\n13,623\n6,786, 20,461\n&lt;0.001\n\n\n    West\n28,671\n19,552, 37,790\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-13,690\n-20,647, -6,732\n&lt;0.001\n\n\n    Small\n-14,909\n-22,234, -7,584\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n21,023\n15,334, 26,712\n&lt;0.001\n\n\n    Urban, teaching\n25,163\n19,123, 31,203\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2,629\n-9,148, 14,405\n0.7\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-2,537\n-8,661, 3,588\n0.4\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-3,942\n-11,726, 3,842\n0.3\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-8,216\n-19,453, 3,022\n0.2\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n13,766\n1,928, 25,604\n0.023\n\n\n\nAbbreviation: CI = Confidence Interval"
  }
]